IN8BIO, INC. Files 8-K Report
Ticker: INAB · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1740279
| Field | Detail |
|---|---|
| Company | In8bio, Inc. (INAB) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, 8-K
TL;DR
IN8BIO filed an 8-K, updated address and former name Incysus Therapeutics.
AI Summary
On June 2, 2025, IN8BIO, INC. filed an 8-K report. The filing indicates the company's principal executive offices are located at 350 5th Avenue, Suite 5330, New York, NY 10118. The report also lists the company's former name as Incysus Therapeutics, Inc., with a name change date of May 10, 2018.
Why It Matters
This 8-K filing provides updated corporate information for IN8BIO, INC., including its current address and a historical name change, which is important for tracking corporate identity and structure.
Risk Assessment
Risk Level: low — This filing is a routine corporate update and does not appear to contain significant financial or operational news that would immediately impact the company's risk profile.
Key Players & Entities
- IN8BIO, INC. (company) — Registrant
- Incysus Therapeutics, Inc. (company) — Former Company Name
- 350 5th Avenue, Suite 5330, New York, NY 10118 (location) — Principal Executive Offices
- May 10, 2018 (date) — Date of Name Change
- June 2, 2025 (date) — Date of Report
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is IN8BIO, INC.
What is the address of IN8BIO, INC.'s principal executive offices?
The address of IN8BIO, INC.'s principal executive offices is 350 5th Avenue, Suite 5330, New York, New York 10118.
What was IN8BIO, INC.'s former company name?
IN8BIO, INC.'s former company name was Incysus Therapeutics, Inc.
On what date did the company change its name from Incysus Therapeutics, Inc.?
The date of the name change from Incysus Therapeutics, Inc. was May 10, 2018.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is June 2, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding IN8BIO, INC. (INAB).